v3.24.1.u1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets: Ìý Ìý
Cash and cash equivalents $ 75,639 $ 95,881
Accounts receivable, net 111,367 123,379
Inventory, net 59,366 65,697
Other current assets and prepaid expenses 24,652 24,519
Assets held for sale 120,279 0
Total current assets 391,303 309,476
Property, plant and equipment, net 64,165 75,429
Intangible assets, net 680,034 740,283
In-process research and development 195,000 195,000
Goodwill 530,615 598,260
Investments 40,990 16,082
Operating lease right-of-use assets 63,331 68,088
Other assets 8,578 9,080
Total assets 1,974,016 2,011,698
Current liabilities: Ìý Ìý
Accounts payable 71,157 69,677
Accrued expenses 88,772 90,086
Current maturities of operating leases 11,742 12,996
Current portion of convertible notes 170 0
Current portion of lines of credit and notes payable 22,820 27,293
Liabilities associated with assets held for sale 9,677 0
Total current liabilities 204,338 200,052
Operating lease liabilities 50,931 54,140
Long term portion of convertible notes 323,108 214,325
Deferred tax liabilities 121,635 126,773
Other long-term liabilities, principally contract liabilities, contingent consideration and lines of credit 21,196 27,189
Total long-term liabilities 516,870 422,427
Total liabilities 721,208 622,479
Equity: Ìý Ìý
Common Stock - $0.01 par value, 1,000,000,000 shares authorized; 726,791,854 and 781,936,885 shares issued at March 31, 2024 and December 31, 2023, respectively 7,269 7,820
Treasury Stock - 29,772,753, and 8,655,082 shares at March 31, 2024 and December 31, 2023, respectively (1,791) (1,791)
Additional paid-in capital 3,386,147 3,433,006
Accumulated other comprehensive loss (45,195) (38,030)
Accumulated deficit (2,093,622) (2,011,786)
Total shareholders’ equity 1,252,808 1,389,219
Total liabilities and equity $ 1,974,016 $ 2,011,698

Source

HTML PDF
ZIP